12 9 6 3 0

Survivors Single OF (non-survivors) MOF (non- survivors)

7
5 3

35 30 25

First group

Second group

days

31.8+7

15 10 5 0

26+8.1

20

Surivors

Non-Survivors

12.8+3.2

12.5+3

Comparison between IL-6 assay levels of survivors in both groups at preoperative, 3rd, 7th and 14th
2000
Group I Group II

IL-6 assay (pg/ml)

1600 1200 800 400 0

Preop.
Preop. day(1)

3rd P.O. 7th P.O. Postoperative days

3rd PO day(2)

14th P.O.
14th PO day(4)

7th PO day(3)

First group
Second group

555+147

973+629

896+568

450+336
362+289

538+137 819+685 680+303 (1), (2), (3), (4) -value > 0.4376

Comparison between TNF- assay levels of survivors in both groups at preoperative, 3rd, 7th and 14th
TNF-alpha assay (pg/ml)
Group I

1600

Group II

1200

800

400

Preop.

3rd P.O. 7th P.O. Postoperative days

14th P.O.

Preop. day(1)

3rd PO day(2)

7th PO day(3)

14th PO day(4)

First group
Second group

403+118

450+75

406+187

148+50
170+67

360+122 422+115 402+141 (1), (2), (3), (4) -value > 0.4376